ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 106 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $513 | +1.2% | 155 | 0.0% | 0.00% | – |
Q1 2024 | $507 | -6.8% | 155 | 0.0% | 0.00% | – |
Q4 2023 | $544 | -47.4% | 155 | 0.0% | 0.00% | -100.0% |
Q3 2023 | $1,035 | -20.4% | 155 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $1,300 | -15.5% | 155 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,539 | +42.6% | 155 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,079 | +7.9% | 155 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,000 | -66.7% | 155 | -79.7% | 0.00% | -50.0% |
Q2 2022 | $3,000 | -75.0% | 765 | -72.3% | 0.00% | -75.0% |
Q1 2022 | $12,000 | 0.0% | 2,765 | -11.2% | 0.01% | 0.0% |
Q4 2021 | $12,000 | -70.0% | 3,115 | -31.6% | 0.01% | -72.4% |
Q3 2021 | $40,000 | -18.4% | 4,557 | +4.5% | 0.03% | -19.4% |
Q2 2021 | $49,000 | +390.0% | 4,360 | +407.6% | 0.04% | +350.0% |
Q1 2021 | $10,000 | – | 859 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |